Non-Hodgkins Lymphoma Studies Currently Recruiting Participants at the
|
Protocol Title |
Study # |
Study Group |
|
A Phase II Epothilone B analog BMS-247550 in patients with relapsed aggressive Non-Hodgkin’s Lymphoma |
06-152 |
SCCI/UOC |
|
Contact: Merri Ellen King 217-545-1190, Susan Klug 217-545-7929 |
||
|
Protocol Title |
Study # |
Study Group |
|
A Phase III open-label randimized, study of Inotuzumab Ozogamicin (CMC-544) administraion in combination with Rituximab compared to a defined investigator’s choice therapy in subjects with relapsed or refractory, CD22-positive follicular B-Cell non-Hodgkin’s Lymphoma |
08-009 |
SCCI |
|
Contact: Susan Klug 217-545-7929 |
||
Although our objective is to provide an updated listing of available clinical trials please note that a listing here does not guarantee that a trial is open or available to any specific patient and that there may be additional trials available that are not listed. Complete information is only available from a treating physician.
Back to Open Clinical Trials
Cancer Institute Home / Administration / Grants & Funding / Clinics & Physicians / Make an Appointment
Research & Clinical Trials / Outreach & Resources / Maps & Locations / Comments & Feedback / Members Only
SIU-SM Home / About SIU-SM / Directories / News / SIU Carbondale / Search
Last Modified 00/00/00
Contact the webmaster / Copyright 2008 Board of Trustees, Southern Illinois University
